(Q43175734)

15 November 2017

title

Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea (English)

1 reference

15 November 2017

1 reference

1 reference

2

Youn Jeong Lee

1 reference

15 November 2017

4

Hyun Mi Kang

1 reference

15 November 2017

7

Jae Hong Kim

1 reference

15 November 2017

Jae Min Song

1

1 reference

15 November 2017

Ok Mi Jeong

3

1 reference

15 November 2017

Hye Ryoung Kim

5

1 reference

15 November 2017

Jun Hun Kwon

6

1 reference

15 November 2017

Baik Lin Seong

8

1 reference

15 November 2017

Yong Joo Kim

9

1 reference

15 November 2017

publication date

16 February 2008

1 reference

15 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Veterinary Microbiology

1 reference

15 November 2017

volume

130

1 reference

15 November 2017

issue

3-4

1 reference

15 November 2017

page(s)

268-276

1 reference

Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Continuing evolution of H9N2 influenza viruses in Southeastern China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Eight-plasmid system for rapid generation of influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Universal primer set for the full-length amplification of all influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

H9N2 influenza viruses isolated from poultry in Korean live bird markets continuously evolve and cause the severe clinical signs in layers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Continuing evolution of H9 influenza viruses in Korean poultry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Immunity to influenza A H9N2 viruses induced by infection and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Avian influenza virus (H5N1): a threat to human health.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Human infection with influenza H9N2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

Isolation and characterization of conglutinin as an influenza A virus inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETMIC.2008.02.005

10.1016/J.VETMIC.2008.02.005

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference